These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15338151)

  • 1. [Guidelines: acute coronary syndrome (ACS)].
    Schwaab B
    Z Kardiol; 2004 Aug; 93(8):634-5; author reply 635-6. PubMed ID: 15338151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment strategy of unstable angina and non-ST-segment elevation myocardial infarction].
    Zaliūnas R
    Medicina (Kaunas); 2002; 38 Suppl 2():11-4. PubMed ID: 12560610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coronary syndromes in the elderly].
    Bounhoure JP; Carrié D; Puel J
    Bull Acad Natl Med; 2006; 190(4-5):807-16; discussion 816, 873-6. PubMed ID: 17195608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In acute coronary syndrome. Seize platelets with pliers].
    MMW Fortschr Med; 2002 Nov; 144(45):61. PubMed ID: 12534069
    [No Abstract]   [Full Text] [Related]  

  • 7. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications of treatment with clopidogrel in the guidelines of the Spanish Society of Cardiology for unstable angina/non-ST-segment elevation acute myocardial infarction].
    Valentín Segura V
    Rev Esp Cardiol; 2002 Nov; 55(11):1217-8; author reply 1218. PubMed ID: 12423582
    [No Abstract]   [Full Text] [Related]  

  • 10. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel in patients with acute coronary syndromes: learning from clinical practice.
    Ziegelstein RC
    Arch Intern Med; 2006 Nov; 166(20):2292-3; author reply 2293. PubMed ID: 17101958
    [No Abstract]   [Full Text] [Related]  

  • 12. New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion.
    Howard PA
    Ann Pharmacother; 2002 Nov; 36(11):1800-4. PubMed ID: 12432893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
    MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute coronary syndrome: when an indication for clopidogrel?].
    Köster R
    Dtsch Med Wochenschr; 2006 Dec; 131(50):2864. PubMed ID: 17160771
    [No Abstract]   [Full Text] [Related]  

  • 15. Building evidence for early initiation of clopidogrel loading in non-ST-segment elevation acute coronary syndromes: going past the American College of Cardiology/American Heart Association guidelines.
    Aghababian RV
    Ann Emerg Med; 2004 May; 43(5):666-8; author reply 668-9. PubMed ID: 15259150
    [No Abstract]   [Full Text] [Related]  

  • 16. [New US guidelines. Myocardial infarct is now treated more aggressively].
    MMW Fortschr Med; 2002 May; 144(20):64. PubMed ID: 12119892
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 18. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.
    Wiviott SD; White HD; Ohman EM; Fox KA; Armstrong PW; Prabhakaran D; Hafley G; Lokhnygina Y; Boden WE; Hamm C; Clemmensen P; Nicolau JC; Menozzi A; Ruzyllo W; Widimsky P; Oto A; Leiva-Pons J; Pavlides G; Winters KJ; Roe MT; Bhatt DL
    Lancet; 2013 Aug; 382(9892):605-13. PubMed ID: 23953385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.
    Clemmensen P; Roe MT; Hochman JS; Cyr DD; Neely ML; McGuire DK; Cornel JH; Huber K; Zamoryakhin D; White HD; Armstrong PW; Fox KA; Prabhakaran D; Ohman EM;
    Am Heart J; 2015 Oct; 170(4):695-705.e5. PubMed ID: 26386793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
    Di Nisio M; Bijsterveld NR; Meijers JC; Levi M; Büller HR; Peters RJ
    J Am Coll Cardiol; 2005 Oct; 46(8):1582-3. PubMed ID: 16226189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.